ADM Diagnostics
ADMdx is a medical technology company specializing in the diagnosis and treatment of brain disorders, particularly Alzheimer's disease and other dementias. They leverage advanced imaging biomarkers, AI, and a proprietary database of tens of thousands of PET and MRI scans with associated clinical and fluid biomarker data to provide earlier and more accurate disease identification. ADMdx offers both a diagnostic product, CorInsights® MRI, which provides quantitative information about brain tissue volume from standard MRI scans, and comprehensive imaging CRO services for CNS clinical trials. Their services include protocol development, site qualification, data management, radiology reads, and advanced image analysis, all aimed at supporting clinical trial success through clarity, quality, partner focus, and insight. The company's technology and expertise are applied to characterizing disease progression, identifying patient cohorts for trials, and detecting treatment effects, with a focus on improving patient outcomes and advancing drug development.
ADM Diagnostics
ADMdx is a medical technology company specializing in the diagnosis and treatment of brain disorders, particularly Alzheimer's disease and other dementias. They leverage advanced imaging biomarkers, AI, and a proprietary database of tens of thousands of PET and MRI scans with associated clinical and fluid biomarker data to provide earlier and more accurate disease identification. ADMdx offers both a diagnostic product, CorInsights® MRI, which provides quantitative information about brain tissue volume from standard MRI scans, and comprehensive imaging CRO services for CNS clinical trials. Their services include protocol development, site qualification, data management, radiology reads, and advanced image analysis, all aimed at supporting clinical trial success through clarity, quality, partner focus, and insight. The company's technology and expertise are applied to characterizing disease progression, identifying patient cohorts for trials, and detecting treatment effects, with a focus on improving patient outcomes and advancing drug development.